Reply  by Rao, Sunil V. & Gilchrist, Ian C.
R
o
fl
d
t
A
*
*
1
H
H
E
R
1
2
3
4
5
R
W
r
F
a
w
r
a
i
b
m
S
d
r
o
d
u
(
a
v
i
w
e
(
t
i
c
s
p
o
*
I
*
D
E
R
1
2
3
4
5
6
7
1266 Correspondence JACC Vol. 56, No. 15, 2010
October 5, 2010:1263–6APTOR study demonstrates that it is safe and effective to change
ur clinical practice even from one day to the other. Longer
uoroscopic times might be attributable to the manipulation
uring the diagnostic phase that can be significantly reduced by
raining and experience.
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eply
e thank Drs. Komo´csi and Aradi for their insight regarding our
eview (1) of transradial percutaneous coronary intervention (PCI).
irst, we agree that practice change from femoral to a radial
pproach is feasible. We changed to the radial approach while
orking in predominantly transfemoral catheterization laborato-
ies. We also agree that procedure and fluoroscopy times, as well as
ccess site crossover rates, can be reduced significantly with
ncreased radial experience.
Second, they are correct that the mortality risk associated with
leeding may be dependent on the patient’s presentation (2). Their
eta-analysis of studies comparing radial and femoral PCI in acute
T-segment elevation myocardial infarction (3) is provocative but
oes not provide definitive evidence that transradial PCI directly
educes mortality. Their analysis included both randomized andbservational comparisons of radial and femoral PCI. This intro-
uces confounding into the analysis because the radial approach is
sed more often in patients at lower risk for bleeding and ischemia
4), and subsequently who are at lower risk for mortality. In
ddition, transradial PCI directly reduces bleeding only at the
ascular access site. Two studies (5,6) have demonstrated that
solated groin hematomas, the most common type of bleeding seen
ith transfemoral PCI, do not correlate with mortality. With the
xception of preventing retroperitoneal hematomas or transfusion
7), it is difficult to explain the mortality reductions seen with
ransradial PCI in observational studies. A well-designed, random-
zed, international trial is still needed before one can definitively
onclude that transradial PCI reduces mortality. The success of
uch a trial depends on the willingness of operators to randomize
atients to either a radial or femoral approach, rather than relying
n observational data to drive a major shift in clinical practice.
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